Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 27, 2009
Influence of dose and frequency of antigen injection on IgE development in young children: a comparison of fire ant stings and tetanus immunizationsDennis R Ownby, Megan E Partridge, Ganesa R Wegienka, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 22, 2010
Variation of dust endotoxin concentrations by location and time within homes of young childrenDennis R Ownby, Edward L Peterson, L Keoki Williams, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 14, 2020
Suppression tumorigenicity 2 (ST2) turbidimetric immunoassay compared to enzyme-linked immunosorbent assay in predicting survival in heart failure patients with reduced ejection fractionLindsey Aurora, Edward Peterson, Hongsheng Gui, et al.
The Journal of Allergy and Clinical Immunology|October 25, 2011
Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherenceL Keoki Williams, Edward L Peterson, Karen Wells, et al.
The Journal of Allergy and Clinical Immunology. Global|February 9, 2026
Distinct blood transcriptomic profiling underlying asthma establishment and exacerbationBaojun Wu, Mao Yang, Donglei Hu, et al.
Journal of the American Heart Association|May 10, 2018
Race and Beta-Blocker Survival Benefit in Patients With Heart Failure: An Investigation of Self-Reported Race and Proportion of African Genetic AncestryJasmine A Luzum, Edward Peterson, Jia Li, et al.
Diabetes Care|December 24, 2005
A single factor underlies the metabolic syndrome: a confirmatory factor analysisManel Pladevall, Bonita Singal, L Keoki Williams, et al.
Journal of Cardiovascular Translational Research|May 16, 2023
Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure PatientsJoseph Debbs, Bashar Hannawi, Edward Peterson, et al.
Pageof 17